ACTRN12623000812695招募中2 期
Efficacy and safety of prehospital fibrinogen early in severe trauma study: A fphase II study (PRE-FEISTY II)(Stage 1)
ew South Wales Ambulance0 个研究点目标入组 23 人开始时间: 2023年7月27日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 招募中
- 发起方
- 入组人数
- 23
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Non-randomised trial
- 主要目的
- Treatment
- 盲法
- Open (masking not used)
入排标准
- 年龄范围
- 18 Years 至 o limit（—）
- 性别
- All
入选标准
- •Adult patient (aged greater than or equal to 18 years).
- •Judged to have ongoing haemorrhage by the treating clinician.
- •Receiving pre-hospital blood transfusion
排除标准
- •1.Injury judged incompatible with survival
- •2.Enrolment unable to occur within 6 hours of injury
- •3.Known pregnancy
- •4.Known genetic or drug induced coagulation disorder
- •5.Known objection to blood products
- •6.Dedicated prior fibrinogen replacement
- •7.Participation in a competing study
研究者
相似试验
招募中
2 期
Efficacy and safety of early fibrinogen concentrate substitution therapy for severe trauma patients receiving massive transfusions: prospective single arm clinical trialsevere traumaJPRN-UMIN000010294Saitama Medical Center, Saitama Medical University30
进行中（未招募）
不适用
Efficacy and safety of Fibrinogen Concentrate (Human) for on-demand treatment of acute bleeding in subjects with congenital fibrinogen deficiency - NDCongenital fibrinogen deficiency ( afibrinogenemia, severe hypofibrinogenemia)MedDRA version: 9.1Level: LLTClassification code 10016075EUCTR2007-004088-22-ITCSL BEHRING GmbH23
进行中（未招募）
不适用
Efficacy and safety of Fibrinogen Concentrate (Human) for on-demand treatment of acute bleeding in subjects with congenital fibrinogen deficiencyFibrinogen Concentrate (Human) (FCH) - efficacy and safetyCongenital fibrinogen deficiency (afibrinogenemia, severe hypofibrinogenemia)MedDRA version: 12.0Level: LLTClassification code 10016075Term: Factor I deficiencyEUCTR2007-004088-22-DECSL Behring GmbH23
尚未招募
3 期
The administration of fibrinogen concentrate (a component of blood involved in clotting process) to be given to those women who, after delivery of babies, develop severe bleeding to establish if this drug will prevent further blood loss or reduce the volume of blood loss.Post partum haemorrhageReproductive Health and Childbirth - Childbirth and postnatal careBlood - Clotting disordersACTRN12614000691640Auckland City Hospital245
尚未招募
不适用
Pre-hospital Administration of Fibrinogen in Trauma-Induced CoagulopathyTrauma Induced CoagulopathyNCT06582420Unidade Local de Saude do Arco Ribeirinho52